Research shows new drug combination effective for patients with advanced ovarian cancer
A new study led by researchers at Yale Cancer Center and the University of Maryland Comprehensive Cancer Center shows ixabepilone plus bevacizumab (IXA+BEV) is a well-tolerated, effective combination for treatment of platinum/taxane-resistant ...
Feb 14, 2022
0
19